A Survey to Assess the Incidence and Characteristics of Melanoma in Parkinson's Disease Patients
N/A
N/A
N/A
N/A
N/A
Not Enrolling
Both
Parkinson's Disease, Malignant Melanoma
Both
Parkinson's Disease, Malignant Melanoma
Trial Information
A Survey to Assess the Incidence and Characteristics of Melanoma in Parkinson's Disease Patients
Inclusion Criteria:
Confirmed diagnosis Parkinson's disease Patient able and willing to give informed consent
Patient must not be taking any investigational drug at the time of enrollment
Exclusion Criteria:
unconfirmed, undocumented Parkinson's disease unable to give consent taking any
investigational product
Type of Study:
Observational
Study Design:
N/A
Principal Investigator
Bruce Schwartz, Ph.D.
Investigator Role:
Study Director
Investigator Affiliation:
Teva Neuroscience, Inc.
Authority:
United States: Food and Drug Administration
Study ID:
EP002
NCT ID:
NCT00203008
Start Date:
January 2003
Completion Date:
September 2003
Related Keywords:
- Parkinson's Disease
- Malignant Melanoma
- Melanoma
- Parkinson Disease
Name | Location |
|---|
